Medco E&P Indonesia is a subsidiary of Medco Energi Internasional Tbk, dedicated to oil and gas operations in Indonesia. With a focus on upstream activities including exploration, development, and production of crude oil and natural gas, the company manages a total of 15 oil and gas assets in Indonesia, with 12 currently in production. In 2023, these assets exceeded production targets, contributing 143 mboepd.
The company is committed to maintaining the highest standards and best practices throughout its operations and has made significant progress on ESG commitments. In 2023, it implemented 41 GHG emission reduction initiatives, resulting in a reduction of 147,963 tCO2e/year. Additionally, 143,883 trees were planted across their sites with a commitment to their maintenance. Medco E&P Indonesia is also progressing CCS studies at the Natuna, Corridor, and South Sumatera PSCs.
The last investment in Medco E&P Indonesia was a $500.00M Post-IPO Debt investment on 20 October 2023.
With its dedication to sustainable environmental practices and its ongoing production success, Medco E&P Indonesia presents a strong investment opportunity in the Oil and Gas industry within Indonesia.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Post-IPO Debt | $500.00M | - | 20 Oct 2023 |
No recent news or press coverage available for Medco E&P Indonesia.